Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial

Authors:

Abstract
No abstract available
Funding Information
  • European Union's Seventh Framework Programme (261954)

This publication has 29 references indexed in Scilit: